LICA PHARMACEUTICALS ApS: Financial statements 2022
CVR: 25332520
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 312,597 and a net result of DKK -1,524,785 compared with DKK 2,563,807 the year before. That is a decrease of 15.7% compared with the year before. Equity in the 2022 report amounted to DKK 20,632,693. The solvency ratio was 99.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 312,597
- Profit/Loss
- DKK -1,524,785
- Equity
- DKK 20,632,693
- Total Assets
- DKK 20,729,789
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 313 t. | -1.5 mio. | 20.6 mio. | 1 |
| 2021 | - | 371 t. | 2.6 mio. | 22.2 mio. | 1 |
| 2020 | - | 326 t. | 844 t. | 19.6 mio. | 0 |
| 2019 | - | 280 t. | 2.8 mio. | 18.8 mio. | - |
| 2018 | - | 973 t. | 5.6 mio. | 18.4 mio. | - |
Official annual report
Keep an eye on LICA PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
LICA PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 370,721, and the net result was DKK 2,563,807.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.